RE: "immortal time bias in pharmacoepidemiology"

American Journal of Epidemiology

Volumn 170, Issue 5, 2009, Pages 667-668

  Kiri, Victor A ^a,b   MacKenzie, Gilbert ^b  

^a PAREXEL INTERNATIONAL   (United States)

^b UNIVERSITY OF LIMERICK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; LETTER; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PROPORTIONAL HAZARDS MODEL; RISK; TIME; EPIDEMIOLOGY; NOTE;

BIAS (EPIDEMIOLOGY); HUMANS; PHARMACOEPIDEMIOLOGY; TIME FACTORS;

EID: 70249147643     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwp239     Document Type: Letter

References (7)

1. Kraemer HC. Events per person-time (incidence rate): a misleading statistic? Stat Med. 2009;28(6):1028-1039.
2. Clayton D, Hills M. Statistical Methods in Epidemiology. Oxford, United Kingdom: Oxford University Press; 1993.
3. Bunday BD, Kiri VA. Analysis of censored recidivism data using a proportional hazards-type model. Statistician. 1992; 41:85-96.
4. Kiri VA, Pride NB, Soriano JB, et al. Inhaled corticosteroids in chronic obstructive pulmonary disease: results from two observational designs free of immortal time bias. Am J Respir Crit Care Med. 2005;172(4):460-464.
5. Suissa S. Observational studies of inhaled corticosteroids in chronic obstructive pulmonary disease: misconstrued immortal time bias [letter]. Am J Respir Crit Care Med. 2006;173(4): 464.
6. Kiri VA, Pride NB, Soriano JB, et al. Observational studies of inhaled corticosteroids in chronic obstructive pulmonary disease: misconstrued immortal time bias [letter]. Am J Respir Crit Care Med. 2006;173(4):464-465.
7. Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6):932-946.